[Special announcement] on the innovative biologic drug "Alito"

Article Summary.

Special Announcement Dear Acromegaly Patient: Based on the results of existing preclinical studies, and after the expert panel's validation and approval, our first-ever neurological repair [...]...

special announcement

Dear Tachyzoites.

radical (chemistry)Based on the results of pre-clinical studies and after the demonstration and approval by the expert group, our first innovative biologic drug "Alitol" with nerve repair efficacy is now undergoing investigator-initiated trial (IIT) in accordance with the relevant laws and regulations of the State, and the IIT partner hospitals are limited to Beijing Tiantan Hospital of Capital Medical University and Yuquan Hospital of Tsinghua University (Tsinghua University Hospital of Integrative Medicine). The partner hospitals of IIT are limited to Beijing Tiantan Hospital of Capital Medical University and Yuquan Hospital of Tsinghua University (Tsinghua University Hospital of Integrative Medicine and Western Medicine).Other than that, we have not authorized anyone to conduct clinical trial studies at any other institutions.Please inform your patients.

It is hereby declared.

Beijing Darwin Cell Biotechnology Co.

February 23, 2024